Consequences of disclosing clinical trial results: Evidence from the food and drug administration amendments act

We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics, and pr...

全面介紹

Saved in:
書目詳細資料
Main Authors: BORVEAU, Thomas, CAPKUN, Vedran, WANG, Yin
格式: text
語言:English
出版: Institutional Knowledge at Singapore Management University 2020
主題:
在線閱讀:https://ink.library.smu.edu.sg/soa_research/1838
https://ink.library.smu.edu.sg/context/soa_research/article/2865/viewcontent/SSRN_id3533305.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍